ONE-WAYOngoing theme · still written in the latest filings
End-to-end in-house structure spanning research and development, manufacturing and sales
A policy for building a future pharmaceutical company and business structure that covers the entire process, from research and development through regulatory approval, manufacturing and sales, through the company itself, its affiliated companies and its partner companies.
Companies8How many companies write about this.
Threads9One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhelps8 helps · 0 hurts · 1 flat